
Nutra Pharma Comments on SEC Complaint
Contact: Nutra Pharma Corp. Nina Goldstein 877-895-5647 IR@nutrapharma.com Nutra Pharma is providing comments on the SEC Complaint filed against Nutra Pharma, its CEO and a Consultant to the company. September 28, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), provided the following comment on the lawsuit filed by the U.S. Securities and Exchange Commission earlier today. “Nutra Pharma Corporation learned today that the Securities and Exchange Commiss

Nutra Pharma announces updates with EuroAmerican IP & BioArmor, LLC, a Service Disabled Veteran-
Contact: Nutra Pharma Corp. Nina Goldstein 877-895-5647 IR@nutrapharma.com Nutra Pharma is providing an update on the work of EuroAmerican IP, LLC to create awareness and sales into military and governmental buyers. September 25, 2018 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTC: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today that their work with EuroAmerican IP, LLC has